ZOETIS (ZTS) Stock: Buy, Sell, or Hold?
$83.82
+0.86 (+1.04%)
▲
5d:
+5.57%
30d:
+6.89%
90d:
+14.87%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Nov 05, 2026
0d
Protect ZTS Gains
Updated Nov 13, 12:00 AM ET
QUANTITATIVE VERDICT
WAIT
LOW Confidence (24%)
Quality Score
38/100
Position
EXTENDED
30-Day Fair Range
$74.99 – $83.28
Position: EXTENDED
Forward P/E & Valuation
13.1x
FAIR
vs 13.8x historical avg
Wall Street Target
$89.69
+7.0% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$78.63 / $89.29
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: ZTS shows conflicting indicators. Wait for confirmation before entering.
Smart Money Distribution
Options positioning is turning defensive after a sharp run-up - a pattern consistent with institutional profit-taking. View Scanner →
Signal fired Nov 3, 2026 at $82.99 · last confirmed Nov 13, 2026
Strength: 6.5/10
Get Alerted When ZTS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$100.54
Based on 2.7% avg growth
INTRINSIC VALUE TODAY
$62.43
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 13.8x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ZTS is currently trading at $83.82, which is considered extended relative to its 30-day fair value range of $74.99 to $83.28. The stock's valuation (Forward PE: 13.1) is in line with its historical norms (13.8). Remarkably, the market is currently pricing in an annual earnings decline of 1.6% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, ZTS is in a strong downtrend. Immediate support is located at $78.63, while resistance sits at $89.29.
Market Sentiment: ZTS scores 26/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ZTS is in a strong downtrend. Immediate support is located at $78.63, while resistance sits at $89.29.
Market Sentiment: ZTS scores 26/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$74.99 -
$83.28
Company Quality Score
38/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
23.8%
Trading Range & Key Levels
30-Day Trading Range
$74.99 -
$83.28
Current vs Trading Range
EXTENDED
Support Level
$78.63
Resistance Level
$89.29
Current Trend
Strong Downtrend
Technical data as of
Nov 13, 2026
Protect Your Profits
Holding ZTS? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanQuantitative Signal Breakdown
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (26/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($89.69)
- WARNING: Composite score 38/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
13.14
Wall Street Target
$89.69
(+7.0%)
Revenue Growth (YoY)
-1.3%
Earnings Growth (YoY)
-11.8%
Profit Margin
26.4%
Valuation Discount vs History
-1.6% cheaper
PE vs Historical
13.1 vs 13.8
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-1.6%
(market-implied from PE analysis)
1-Year Target
$82.48
(-2%)
2-Year Target
$81.16
(-3%)
3-Year Target
$79.86
(-5%)
3-Yr Target (if PE normalizes)
(PE: 13→14)
$83.86
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: 1.4%)
$131.88
(+57%)
Base:
(SPY PE: 13.1, Growth: 1.4%)
$87.27
(+4%)
Bear:
(PE: 11.2, Growth: 1.4%)
$74.18
(-12%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (14x PE), but valuation improves significantly next year (13x PE) as earnings recover.
Trailing PE: 14.11 | Current EPS (TTM): $5.88
Bull Case
$98.99
(+18%)
Analyst growth 8.5%, PE expands to 15.5
Base Case
$89.99
(+7%)
Market implied 8.5%, PE stable at 14.1
Bear Case
$56.41
(-33%)
Severe decline -20.0%, PE contracts to 12.0
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 13.1 to 13.8
Stabilization Target:
$88.02
(+5.0%)
PE Expansion Potential:
+5.0%
Share ZTS Analysis
Share this live ZTS analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (ZTS)
Bearish
2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 6, 2026
Daily AI digest
AI Retail Discussion Summary:
Zoetis reported Q3 2026 earnings with a diversified portfolio providing resilience, despite competitive pressures in the companion animal segment and softened U.S. clinic visits. Management raised expectations for adjusted diluted earnings per share.
Key Retail Themes:
Earnings Report
Company Performance
Competitive Landscape
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 14, 2026 5:53 AM ET
Data refreshes hourly during market hours. Next update: 6:53 AM
Data refreshes hourly during market hours. Next update: 6:53 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ZTS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
29 analysts |
$208 | 30 SELL |
|
ALKS
Alkermes Plc |
STRONG BUY
20 analysts |
$58 | 39 SELL |
|
TEVA
Teva Pharma Industries L… |
STRONG BUY
15 analysts |
$49 | 47 HOLD |
|
AMLX
Amylyx Pharmaceuticals I… |
STRONG BUY
12 analysts |
$43 | 55 HOLD |
|
AQST
Aquestive Therapeutics I… |
STRONG BUY
9 analysts |
$9 | 59 HOLD |
Advanced ZTS Option Strategies
Professional options setups generated by AI based on today's ZTS price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive ZTS Research Pages
